Clinical Trial Update: A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia [NA]

View source ↗

Summary

This document reports the completion of a feasibility study evaluating the Nativis Voyager System in patients with recurrent glioblastoma multiforme in Australi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Nativis Voyager System

Snippet

Sponsor: Nativis, Inc. | Conditions: Glioblastoma Multiforme | NA | Status: COMPLETED